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Dematiaceous fungi have melanin-like pigments in the cell walls and infections caused by them are known as phaeohyphomycosis. Cerebral phaeohyphomycosis 
(CP) is a rare but generally fatal systemic infection caused 
by neurotropic fungi belonging to the order Chaetothyriales 
(ascomycete), predominant species being Cladophialophora 
bantiana, Exophiala dermatitidis, and Rhinocladiella mackenziei. 
They are environmental fungi and opportunistic pathogens [1]. 
Although rare, infections caused by dematiaceous fungi are 
being increasingly recognized in both immunocompromised and 
immunocompetent humans.
We report a case of CP from north India, in an immunocompetent 
male, initially diagnosed and managed as cerebral tuberculoma. 
Correct diagnosis followed microscopy and culture with 
successful outcome through surgery and antifungal therapy.
CASE REPORT
A 53-year-old immunocompetent male was transferred from a 
secondary care hospital. There was a history of jerky movements of 
right upper and lower limbs 18 months back. A magnetic resonance 
imaging (MRI) brain was done which revealed a well-defined ring-
enhancing lesion measuring 2.4 cm × 2.4 cm × 2.5 cm in the left 
frontal lobe lesion with mass effect. On the basis of radiological 
appearance, he was diagnosed as a case of tuberculoma brain. He 
was found to be HIV negative and started on antitubercular therapy 
along with antiepileptic agents. 7 months later, the patient had a 
recurrence of the right focal lower limb seizure with secondary 
generalization and progressive weakness of the right upper and 
lower limbs. He also developed cognitive symptoms in the form 
of impaired recent memory and fluency of speech. History was 
negative for any immune compromise, trauma, or sinusitis. 
Repeat MRI brain showed increase in the size of the lesion with 
conglomeration of multiple lesions and surrounding edema. The 
patient was referred to our center for further management by 
neurosurgeon. The lesion was excised and thick, purulent, non 
foul-smelling pus was received for examination and culture. Ziehl–
Neelsen stain showed no acid-fast bacilli. Septate fungal hyphae 
were seen on Gram’s stain and KOH mount (Fig. 1), based on which 
the patient was promptly started on antifungal therapy (liposomal 
amphotericin B [400 mg IV 24 hourly] and voriconazole [200 mg 
per oral 12 hourly]). Postsurgery, the power was grade 3/5 in the 
right upper limb and 2/5 in the right lower limb with the left half of 
the body being unaffected.
Within 2 weeks, the culture was confirmed to be C. bantiana. 
Olive grey to black velvety growth was seen on Sabouraud’s 
dextrose agar with black pigment on reverse. Lactophenol cotton 
blue mount showed septate, brown hyphae with unbranched wavy 
chains of smooth, and brown single-celled conidia (Fig. 2). It was 
differentiated from other species of Cladophialophora by its 
ability to grow at 42°C.
3 months after surgery, the patient continues to be on liposomal 
amphotericin B and voriconazole. Clinically, he has improved, 
with power in both right limbs being 4/5, is ambulatory without 
support, independent to perform his daily routine and there has 
been no recurrence, although 3 months is too short a time to 
comment on recurrence.
ABSTRACT
Cerebral phaeohyphomycosis (CP), caused by dematiaceous fungi, is a serious form of central nervous system fungal infection. It 
is a rare disease with male predominance, no specific symptoms or signs and is associated with grim prognosis irrespective of the 
immune status of the patient. The disease is difficult to diagnose antemortem, and many cases are accidentally diagnosed during 
surgery or autopsy. The early diagnosis and appropriate treatment remain a challenge. The authors report a misinterpreted case 
of CP in a 53-year-old man without immunodeficiency who showed a favorable outcome after surgical excision and antifungal 
therapy. Therefore, CP should be an important differential in cases of brain abscess.
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DISCUSSION
C. bantiana is a highly neurotropic fungus with melanin, a known 
virulence factor, as in other fungi and has been extensively 
studied in Cryptococcus neoformans. It confers a protection 
from free radicals which are produced by phagocytic cells 
in their oxidative burst that kills most pathogens [2]. Human 
melanin (derived from tyrosine) is biochemically different from 
fungal melanin (derived mostly from acetate) yet sharing the 
same physicochemical properties. A hypothesis that is used 
to explain the metastasis of malignant melanoma to the brain 
can be applied here that, the affinity of melanin to receptors 
on the blood–brain barrier, allows the fungus to penetrate into 
the parenchyma. The primary mechanism for dissemination of 
the fungus is considered hematogenous route, thus majority of 
reported C. bantiana are supratentorial involving the frontal 
lobes [3].
Various workers in their reviews have reported certain 
characteristics of CP caused by C. bantiana. Most patients 
are from Asian countries with immunocompetent male hosts 
with rural origin from India being major contributors. Most 
common complaints reported in order of their presentation 
are hemiparesis, seizures, altered sensorium, fever, vomiting, 
aphasia or dysarthria, and visual disturbances; generally, without 
any features of meningitis. The majority of the patients had 
localized brain abscess with a single ring-enhancing lesion; most 
commonly located in frontal, parietal, and occipital lobes, in order 
of decreasing frequency [2,4,5]. Our patient had similar features, 
by being an Indian, middle-aged, immunocompetent male from 
rural origin. He presented with signs of focal neurological deficit 
(seizures and hemiparesis), no features of meningitis, and solitary 
lesion with ring enhancement located in frontal lobe.
Fungal abscesses caused by C. bantiana cannot be 
differentiated with certainty from other bacterial abscesses or 
central nervous system neoplasia just on the basis of radiologic 
findings and are also known as “the great mimickers.” Irregular 
heterogeneous lesion with mass effect and surrounding 
edema is seen on contrast-enhanced images [3]. In particular, 
differentiating between brain tumors such as high-grade gliomas 
and metastasis, cerebral tuberculomas, and brain abscesses is 
often difficult [6]. Due to these difficulties, the diagnosis is often 
delayed which is the main reason for the high mortality in these 
cases [4].
Diagnosis is confirmed by microscopic analysis of the lesion 
along with demonstration of cultural aspects of the causative 
fungus on which the successful treatment depends [3,5]. Care 
should be taken to avoid the seeding of CSF or the tract while 
removal of the lesion or its contents. Samples should be handled 
in biosafety cabinets because of the known pathogenesis in 
immunocompetent individuals.
There is a dearth of literature of antifungal efficacy in 
human cases of CP and no breakpoints and standardized 
regimens have been established. The agents used include 
amphotericin B, 5-fluorocytosine, voriconazole, fluconazole, 
posaconazole, itraconazole, and ketoconazole [4]. Voriconazole 
is preferred over itraconazole due to better cerebrospinal fluid 
penetration and bioavailability [7]. No significant difference 
in survival was noted with the use of any antifungal agent or 
combination of antifungal agents [4]. A study conducted by 
Den et al. suggest that a combination of amphotericin B and 
flucytosine has a promising role in the treatment of primary CP 
due to neurotropic melanized fungi [1]. Several studies including 
European society of clinical microbiology and infectious diseases 
and European confederation of medical mycology joint guidelines 
have recommended early wide surgical resection followed by 
targeted treatment is required for the best outcome, especially 
once the fungus is identified [1,2,7-9].
Relapses are reported after 3 months to more than a year; hence, 
prolonged follow-ups are advisable. Until complete radiographic 
resolution occurs or there is evidence of no progression on repeat 
imaging over prolonged period, therapy should be continued [8]. 
Only 31 cases have been reported from India (1962 till date) 
to the best of authors’ knowledge. The respective authors have 
mentioned that, in most of these cases, there was no indication 
of fungal infection and one even being masqueraded as cerebral 
tuberculoma [5,10].
Figure 1: Dark and septate fungal hyphae on KOH mount of the 
pus (×40)
Figure 2: LCB mount from culture: Chains of brown, smooth-
walled, single-celled, ellipsoid conidia (×40)
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It is concluded that CP is a rare disease and of a very grim 
nature early diagnosis is therefore mandatory for the rapid 
treatment and survival of patients. Hence, it should be on the list 
of differential diagnosis of brain abscess.
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